Robuta

https://pubmed.ncbi.nlm.nih.gov/34021359/
We conclude that SHPT and hyperphosphataemia are independently associated with CKD progression and the incidence of CVE in CKD patients.
secondary hyperparathyroidismindependenteffectshyperphosphataemiachronic
https://pubmed.ncbi.nlm.nih.gov/8676818/
Calcium-alpha-ketoglutarate (Ca-ket) is known as a highly effective phosphate (P) binder in hemodialysis (HD) patients. In addition, alpha-ketoglutarate has...
long termalpha ketoglutaratesecondary hyperparathyroidismtreatmentcalcium